Vaxcyte, Inc. — Director's Dealing 2022

Jul 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2022-07-26

Reporting Person: PICKERING GRANT (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-26	Common Stock	S	5000	$23.2621	Disposed	167830	Indirect
2022-07-26	Common Stock	S	5000	$23.2706	Disposed	167830	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	683456	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported is a weighted-average price. The shares were sold at prices ranging from $22.99 to $23.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F4: The price reported is a weighted-average price. The shares were sold at prices ranging from $22.965 to $23.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: Shares are held directly by a trust for the benefit of the Reporting Person's son.